Purui Intelligence
璞睿创智
Purui Chuangzhi is a technology company that uses AI to transform pharmaceutical clinical trials, offering an end-to-end intelligent clinical trial platform featuring automated data flow, AI-driven decision-making, and built-in compliance throughout.
Position in SVTR
Snapshot 2026-10-16- Startup SignalsRankedof 2,203↓36
- Life SciencesRankedof 232↓5
- Healthcare ServicesRankedof 83↓6
- Drug DiscoveryTop 50%–
About
Purui Chuangzhi is a technology company that uses AI to transform pharmaceutical clinical trials, offering an end-to-end intelligent clinical trial platform featuring automated data flow, AI-driven decision-making, and built-in compliance throughout. The company has served nearly 300 domestic and international pharmaceutical enterprises and completed close to 600 Phase 1-3 registration and real-world study projects.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Founders / core team
Investors
Funding history
- 2026-06-30Series A$14M
Investors · 住友商事亚洲资本、CICC Capital、苏州高新融晟
Similar companies· Same sector “Life Sciences”
Nabla
Life SciencesNabla, founded in 2018 in Boston, Massachusetts, USA, provides AI assistants for healthcare practitioners that rapidly generate clinical notes across specialties, reducing clinician workload and improving patient care quality.
Scan.com
Life SciencesScan.com, formerly National MRI Scan, was founded in 2017 and is headquartered in London, UK. It operates a two-way API that integrates directly into independent imaging centres' EMR and practice management systems, enabling health plans, self-funded employers, workers' compensation payers and healthtech platforms to search, schedule, price-check and receive digital results for diagnostic imaging, using AI for referral routing and subspecialty radiologist matching. The company has served over 900,000 patients across the US and UK.
PhaseV
Life SciencesPhaseV, founded in 2023 with offices in Boston, USA, and Israel, uses machine learning to help pharmaceutical companies design and analyze adaptive clinical trials, providing tools for adaptive trial design, real-time cohort optimization, and advanced statistical modeling.
Xellar Biosystems
Life SciencesYaoso Technology is a biopharma R&D platform company centered on organ-on-a-chip technology, integrating high-content 3D cell imaging, computer vision, AI, and high-throughput automation. It has built a 3D Bio Intelligence system serving drug discovery and precision medicine, with partnerships including Sanofi.
Drug Farm
Life SciencesInnovative-drug developer using genetics and AI to discover first-in-class targets
Hi Rasmus
Life SciencesHi Rasmus is an ABA (Applied Behavior Analysis)-first clinical technology platform for behavioral health providers, founded in 2019 by Nikolaj Hendriksen after his son Rasmus was diagnosed with autism, prompting Hendriksen to leave Danish fintech and build a company named after his son. Headquartered in Nashville, Tennessee with a team also in Copenhagen, its platform covers clinical data collection, care delivery workflows, scheduling, outcomes reporting and administrative tools, and integrates with practice-management systems such as AlohaABA and Lumary. Previously bootstrapped and profitable, it serves 1,000+ provider organizations across all 50 U.S. states and 90 countries, supporting roughly 19.6 million client-session hours annually.
Investors that may fit
Dimension Capital
10 Life Sciences deals in the last 24 months · 5 at a nearby stage · 1 in 华东
Request intro →OrbiMed Advisors
9 Life Sciences deals in the last 24 months · 5 at a nearby stage · 4 in 华东
Request intro →Qiming Venture Partners
9 Life Sciences deals in the last 24 months · 6 at a nearby stage · 7 in 华东
Request intro →Lilly Asia Ventures
7 Life Sciences deals in the last 24 months · 5 at a nearby stage · 7 in 华东
Request intro →Matrix Partners China
6 Life Sciences deals in the last 24 months · 6 at a nearby stage · 4 in 华东
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.